Cannabinoids Show Promising Anti-Cancer Potential Yet Mechanisms Remain Unclear, New Study
Recent studies have spotlighted the anticancer capabilities of cannabinoids like delta-9 THC, CBD and CBG and their potential to inhibit tumor growth and improve palliative care.
Despite mounting experimental evidence supporting these cannabis compounds’ effectiveness in various cancers, the underlying mechanisms remain unknown.
Key Anticancer Activities Of Cannabinoids
A comprehensive review published in late September in Discover Oncology explores how cannabinoids can modulate signaling pathways critical for cancer cell survival and growth. Researchers underline the pressing necessity to establish standardized therapeutic protocols, especially considering the mixed results cannabinoids have demonstrated across different cancer types.
“Cannabinoids, including Δ9-THC, CBD, and CBG, exhibit significant anticancer activities such as apoptosis induction, autophagy stimulation, cell cycle arrest, anti-proliferation, anti-angiogenesis, and metastasis inhibition,” the authors report.
Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your …